Although research on tissue stem cells as well as ES (embryonic stem) cells and iPS (induced pluripotent stem) cells has rapidly progressed, clinical application of those cells has not been fully developed yet. One of the reasons is that it is not easy to guarantee the safety of the stem cell transplantation.
We want to use skin-derived cells as a stem cell source for the future cell therapy. We are also interested in the characterization of various stem cells. Our final goal is to develop a new method for regenerative medicine based on the basic research.